Gary Lerner

1.2k total citations
20 papers, 632 citations indexed

About

Gary Lerner is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gary Lerner has authored 20 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 5 papers in Pediatrics, Perinatology and Child Health and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gary Lerner's work include Dialysis and Renal Disease Management (5 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Pediatric Urology and Nephrology Studies (3 papers). Gary Lerner is often cited by papers focused on Dialysis and Renal Disease Management (5 papers), Renal Transplantation Outcomes and Treatments (3 papers) and Pediatric Urology and Nephrology Studies (3 papers). Gary Lerner collaborates with scholars based in United States, Tunisia and Norway. Gary Lerner's co-authors include Bradley A. Warady, Steven R. Alexander, Emily Sullivan, Grant C. Whittlesey, Louise Cullen, Jeffrey C. Murray, L Fleischmann, M. D. Klein, Alan D. Perlmutter and Chris Shanley and has published in prestigious journals such as American Journal of Public Health, Transplantation and Developmental Medicine & Child Neurology.

In The Last Decade

Gary Lerner

20 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary Lerner United States 13 231 161 141 114 107 20 632
F Quarello Italy 15 310 1.3× 73 0.5× 109 0.8× 149 1.3× 209 2.0× 89 687
G Rizzoni Italy 16 301 1.3× 125 0.8× 113 0.8× 27 0.2× 181 1.7× 32 758
Ralph J. Caruana United States 16 302 1.3× 79 0.5× 150 1.1× 92 0.8× 175 1.6× 40 733
V. Bonomini Italy 16 422 1.8× 44 0.3× 232 1.6× 96 0.8× 165 1.5× 104 817
Mesiha Ekim Türkiye 18 454 2.0× 87 0.5× 328 2.3× 123 1.1× 293 2.7× 60 947
Aytül Noyan Türkiye 16 319 1.4× 273 1.7× 173 1.2× 46 0.4× 189 1.8× 70 825
Silvana Savoldi Italy 16 410 1.8× 56 0.3× 229 1.6× 79 0.7× 292 2.7× 44 1.1k
Jen-Jar Lin United States 12 358 1.5× 49 0.3× 96 0.7× 22 0.2× 80 0.7× 17 572
Ünal Yasavul Türkiye 15 137 0.6× 55 0.3× 122 0.9× 36 0.3× 182 1.7× 51 585
Chih-Wei Yang Taiwan 15 243 1.1× 21 0.1× 153 1.1× 112 1.0× 163 1.5× 35 591

Countries citing papers authored by Gary Lerner

Since Specialization
Citations

This map shows the geographic impact of Gary Lerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Lerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Lerner more than expected).

Fields of papers citing papers by Gary Lerner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Lerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Lerner. The network helps show where Gary Lerner may publish in the future.

Co-authorship network of co-authors of Gary Lerner

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Lerner. A scholar is included among the top collaborators of Gary Lerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Lerner. Gary Lerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Webb, Nicholas J.A., Gary Lerner, Bradley A. Warady, et al.. (2017). Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatric Nephrology. 32(7). 1221–1232. 7 indexed citations
2.
Mahajan, Vinit B., et al.. (2010). Collagen XVIII mutation in Knobloch syndrome with acute lymphoblastic leukemia. American Journal of Medical Genetics Part A. 152A(11). 2875–2879. 27 indexed citations
3.
Plotkin, Horacio, et al.. (2007). Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study. Developmental Medicine & Child Neurology. 48(9). 709–712. 8 indexed citations
4.
Plotkin, Horacio, et al.. (2006). Low doses of pamidronate to treat osteopenia in children with severe cerebral palsy: a pilot study. Developmental Medicine & Child Neurology. 48(9). 709–709. 46 indexed citations
5.
Warady, Bradley A., Mazen Arar, Gary Lerner, Arline Nakanishi, & Catherine Stehman‐Breen. (2006). Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease. Pediatric Nephrology. 21(8). 1144–1152. 30 indexed citations
6.
Gradman, Wayne S., et al.. (2005). Experience with Autogenous Arteriovenous Access for Hemodialysis in Children and Adolescents. Annals of Vascular Surgery. 19(5). 609–612. 30 indexed citations
7.
Tejani, Amir, Steven R. Alexander, Robert B. Ettenger, et al.. (2004). Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune®, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis1. Pediatric Transplantation. 8(2). 151–160. 33 indexed citations
8.
Lerner, Gary, Arundhati S. Kale, Bradley A. Warady, et al.. (2002). Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease. Pediatric Nephrology. 17(11). 933–937. 44 indexed citations
9.
Morgenstern, Bruce Z., K. S. Nair, Gary Lerner, et al.. (2001). Impact of total body water errors on Kt/V estimates in children on peritoneal dialysis.. PubMed. 17. 260–3. 9 indexed citations
10.
Tejani, Amir, Steven R. Alexander, E. Kohaut, et al.. (1999). SAFETY AND PHARMACOKINETIC PROFILE OF ASCENDING SINGLE DOSES OF ORAL LIQUID SIROLIMUS (Rapamycin) IN PEDIATRIC PATIENTS WITH STABLE CHRONIC RENAL FAILURE.. Transplantation. 67(7). S125–S125. 3 indexed citations
11.
Sherbotie, Joseph R., Timothy E. Bunchman, M. Broyer, et al.. (1999). MYCOPHENOLATE MOFETIL (MMF) ORAL SUSPENSION IN PEDIATRIC RENAL TRANSPLANTATION. Transplantation. 67(7). S125–S125. 2 indexed citations
12.
Lerner, Gary, Bradley A. Warady, Emily Sullivan, & Steven R. Alexander. (1999). Chronic dialysis in children and adolescents. Pediatric Nephrology. 13(5). 404–417. 154 indexed citations
13.
Trembath, Dimitri G., Gary M. Shaw, Karen Todoroff, et al.. (1999). Analysis of select folate pathway genes,PAX3, and humanT in a midwestern neural tube defect population. Teratology. 59(5). 331–341. 76 indexed citations
14.
Trembath, Dimitri G., Gary M. Shaw, Karen Todoroff, et al.. (1999). Analysis of select folate pathway genes, PAX3, and human T in a midwestern neural tube defect population. Teratology. 59(5). 331–341. 5 indexed citations
15.
Lerner, Gary. (1994). Urinary Tract Infections in Children. Pediatric Annals. 23(9). 463–473. 13 indexed citations
16.
Lerner, Gary, et al.. (1992). Renal cortical and renal medullary necrosis in the first 3 months of life. Pediatric Nephrology. 6(6). 516–518. 6 indexed citations
17.
Cullen, Louise, et al.. (1987). Experience with renal failure during extracorporeal membrane oxygenation: Treatment with continuous hemofiltration. Journal of Pediatric Surgery. 22(7). 600–602. 40 indexed citations
18.
Lerner, Gary, L Fleischmann, & Alan D. Perlmutter. (1987). Reflux Nephropathy. Pediatric Clinics of North America. 34(3). 747–770. 28 indexed citations
19.
Cullen, Louise, et al.. (1987). Hypertension during extracorporeal membrane oxygenation: cause, effect, and management.. PubMed. 102(4). 724–30. 51 indexed citations
20.
Coulehan, John L., Gary Lerner, Kathy J. Helzlsouer, Thomas K. Welty, & J. K. McLaughlin. (1986). Acute myocardial infarction among Navajo Indians, 1976-83.. American Journal of Public Health. 76(4). 412–414. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Quarello Breakdown of academic impact, for papers by G Rizzoni Breakdown of academic impact, for papers by Ralph J. Caruana Breakdown of academic impact, for papers by V. Bonomini Breakdown of academic impact, for papers by Mesiha Ekim Breakdown of academic impact, for papers by Aytül Noyan Breakdown of academic impact, for papers by Silvana Savoldi Breakdown of academic impact, for papers by Jen-Jar Lin Breakdown of academic impact, for papers by Ünal Yasavul Breakdown of academic impact, for papers by Chih-Wei Yang
Rankless by CCL
2026